AlphaQuest LLC purchased a new position in Arteris, Inc. (NASDAQ:AIP - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 39,078 shares of the company's stock, valued at approximately $270,000. AlphaQuest LLC owned about 0.09% of Arteris at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Quarry LP bought a new position in shares of Arteris in the 4th quarter worth $46,000. CWM LLC grew its holdings in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after purchasing an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris during the 1st quarter valued at $95,000. D. E. Shaw & Co. Inc. bought a new position in shares of Arteris during the 4th quarter valued at $110,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of Arteris during the 4th quarter valued at $117,000. Institutional investors own 64.36% of the company's stock.
Arteris Trading Down 3.8%
Shares of NASDAQ:AIP traded down $0.37 on Friday, hitting $9.42. The company had a trading volume of 340,309 shares, compared to its average volume of 2,146,041. The firm's 50-day simple moving average is $9.55 and its two-hundred day simple moving average is $8.25. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $14.29.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.
Analysts Set New Price Targets
Several equities research analysts have weighed in on AIP shares. Rosenblatt Securities reissued a "buy" rating and set a $14.00 price target on shares of Arteris in a research report on Wednesday, May 21st. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research report on Saturday. Finally, TD Cowen increased their price target on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $15.00.
View Our Latest Report on AIP
Insider Buying and Selling
In related news, major shareholder Bayview Legacy, Llc sold 50,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the sale, the insider owned 9,839,071 shares in the company, valued at approximately $129,088,611.52. This trade represents a 0.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 94,245 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $13.49, for a total transaction of $1,271,365.05. Following the completion of the sale, the chief executive officer owned 189,785 shares in the company, valued at $2,560,199.65. This represents a 33.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 456,043 shares of company stock valued at $5,484,028 in the last ninety days. Corporate insiders own 33.70% of the company's stock.
Arteris Company Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.